Antibiotic Resistance Could Cause 10M Additional Annual Deaths, Cost $100T By 2050, British Government-Commissioned Report Shows

BBC News: Superbugs to kill ‘more than cancer’ by 2050
“Drug resistant infections will kill an extra 10 million people a year worldwide — more than currently die from cancer — by 2050 unless action is taken, a study says…” (Walsh, 12/10).

Financial Times: Drug resistance to cost $100tn by 2050, study finds
“Without global action, drug resistant infections will cause 10m deaths a year worldwide by 2050 — more than cancer — and will cost at least $100tn during the next 35 years, according to the first economic analysis of the problem…” (Cookson, 12/11).

The Guardian: Drug-resistant infections could lead to 10 million extra deaths a year — report
“…The stark figures, published on Thursday, and believed to be the first to quantify the potential impact of antimicrobial resistance (AMR) — drug-resistant infections or superbugs — will be used to make the case to global leaders that urgent action is needed…” (Siddique, 12/11).

Reuters: Unchecked superbugs could kill 10 million a year, cost $100 trillion
“…Former Goldman Sachs chief economist Jim O’Neill, who led the work, noted that in Europe and the United States alone around 50,000 people currently die each year from infections caused by superbug forms of bacteria such as E. coli…” (Kelland, 12/10).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.